StonvexLoading…
StonvexStonvexStonvexCore line items from TIGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $612.06M | $391.54M | $272.51M | $225.37M |
Operating Income | $207.44M | $81.76M | $45.99M | $2.03M |
Net Income | $171.48M | $61.35M | $33.01M | $-2.26M |
EPS (Diluted) | $0.06 | $0.02 | $0.01 | $0.00 |
Total Assets | $8.23B | $6.39B | $3.75B | $3.80B |
Total Liabilities | $7.36B | $5.73B | $3.25B | $3.35B |
Cash & Equivalents | $791.02M | $393.58M | $322.60M | $277.66M |
Free Cash Flow OCF − CapEx | $1.31B | $826.42M | $-9.33M | $253.17M |
Shares Outstanding | 2.81B | 2.53B | 2.43B | 2.30B |